HIFU treatment for pancreatic cancer will be broadcast on NHK WOLRD

SONIRE Therapeutics Inc. (Headquarters: Shinjuku-ku, Tokyo; President and CEO, Co-Founder: Tohru Satoh; hereinafter referred to as “SONIRE”), announces that NHK WOLRD’s “Medical Frontiers” will focus on HIFU therapy for pancreatic cancer, and the next-generation HIFU (High-Intensity Focused Ultrasound) therapy device, which has been developed by SONIRE, will be introduced in the program.

The program outline is as follows.
Title : Destroying Pancreatic Cancer With Ultrasound
Program Title : NHK World “Medical Frontiers”
Broadcast date and time :
January 8 (Mon) 23:30(JST)
January 9 (Tue) 05:30(JST)  [Rebroadcast]
January 9 (Tue) 12:30(JST)  [Rebroadcast]
January 9 (Tue) 18:30(JST)  [Rebroadcast]
January 27 (Sat) 04:30(JST) [NHK BS1]
Live streaming broadcast :
You can watch the live streaming from the official website.
https://www.nhk.or.jp/nhkworld/en/live/

On-demand Broadcasting :
After the rebroadcast ends, the program can be viewed for one year via on-demand broadcasting.
https://www.nhk.or.jp/nhkworld/en/tv/medicalfrontiers/

For details, please refer to the following URL.
https://www.nhk.or.jp/nhkworld/en/tv/medicalfrontiers/20240108/2050151/

SONIRE will continue to promote our business in order to realize the wish we put in our company name at the time of our foundation: ” Sonics(Ultrasound) Brings New Future to Cancer Patients and Families.”.

The 5th Medical Device Innovation in Kashiwa-no-ha will be held on Tuesday, October 26, 2021, and our representative, Toru Sato, will be speaking at the “Part 2: Presentations by Medical Device Venture Company”.

Tohoku University Business Innovation Center’s Venture Interview article was published

Featured in Bio Startup Directory 2021-2022 (Published by Nikkei BP and released on June 30, 2021)